Ajanta Pharma has informed that a Meeting of the Board of Directors of the Company will be held on January 24, 2017, to consider, approving and taking on record Unaudited (Consolidated & Standalone) Financial Results of the Company for the third quarter ended December 31, 2016 (Q3).
The above information is a part of company’s filings submitted to BSE.